TABLE 4.

Detailed characteristics of reimbursed MAEIs indirectly targeting adherence, identified across 12 European countries.

Nr a	Country	Intervention	Who performs?	Type	Technology mediated?
1	Croatia	Medication review for persons aged over 65 years with three or more prescribed drugs, aiming to increase effectiveness and safety of the therapy	GP	Complex	No
2		Panels for chronic patients (e.g. diabetes, COPD or hypertension) involving monitoring of chronic disease and relevant interventions to improve disease management, e.g. therapy modifications and/or patient education	GP	Complex	No
11	Czech Republic	Patient education about inhalation technique in chronic airways conditions	Nurse	Education	No
12		Assessment of patient risk of drug-related problems, determining his/her pharmacotherapy rationalization plan, provided to inpatients and outpatients	Clinical pharmacists	Medication regimen management	No
13	Estonia	Drug-drug interaction database and clinical decision support system, providing compatibility of the prescribed medicines with all existing medicines	GP	Medication regimen management	Yes
20	Hungary	“Be Educated and Empowered Patient” program aimed at improving health literacy and health behaviour in newly transplanted patients	Patient organisation	Education	No
26	Norway	Patient education in asthma, including checking inhaler use technique	Pharmacists	Education	No
28	Portugal	“Operation Green Light” allowing dispensation of medicines previously available exclusively in hospital pharmacies in community pharmacies	Pharmacists	Medication regimen management	No

^aNumbers refer to consecutive numbers ascribed to interventions across the country related paragraphs, appearing in braces; COPD, chronic obstructive pulmonary disease; GP, general practitioner.